December 2006

Patrick Donnelly Resigns From PRA

Tuesday, December 26, 2006

PRA International announced the resignation of the company’s president and chief executive officer, Patrick Donnelly. He will work as a consultant for 18 months and will receive $2,000 for each day as a consultant. PRA went public, acquired 10 companies and increased its global operations during the past 13 years under Donnelly as CEO.

[Read More]

Hitting For Power

Tuesday, December 19, 2006

There’s been so much written about Pfizer’s failure to get torcetrapib through clinical trials and big pharma’s outdated blockbuster mentality that it’s easy to overlook that pharma is finally making some progress in reducing the huge cost of drug development. And that sometimes going for the home run makes sense.

[Read More]

Radical Thinking On Oncology Funding

Wednesday, December 13, 2006

A deputy director from the National Cancer Institute (NCI) has proposed a radical overhaul of the way NCI allocates oncology clinical trial funding. His proposal would eliminate disparities in oncology clinical trial participation and health outcomes resulting from differences related to race, ethnicity and income. Dr. Jon Kerner, who works in the Division of Cancer Control and Population Sciences, shared his ideas at a recent roundtable held at Baylor College of Medicine.

[Read More]

Top Stories for the Week of Dec. 11th, 2006

Tuesday, December 12, 2006

Top News

Bridgetech Opens New Clinical Research Site in Hong Kong

Bridgetech Holdings International, along with The Chinese University of Hong Kong (CUHK), has opened a new oncology-focused clinical trial site in Hong Kong.

eStudySite Raises $6 Million to Expand with Additional Centers

San Diego, Calif.-based clinical trial management company eStudySite raised $6 million in its first round of institutional financing.

Other breaking news…

[Read More]

Datatrak Forms Enterprise Relationship With GP-Pharm

Tuesday, December 5, 2006

Cleveland, Ohio-based eClinical company Datatrak has formed an enterprise relationship with GP-Pharm, a Barcelona,Spain-based pharmaceutical company focusing on the development of hormonal and cytotoxic drugs. GP-Pharm is a part of the Lipotec Group, a Spanish-owned biochemical manufacturer and supplier of pharmaceutical, cosmetic and food ingredients. Initially, the contract calls for the company to use Datatrak’s EDC Version 4.0 product for a block of five clinical trials enrolling 730 patients and 145 sites. The trials are expected to be conducted in the next 14 months.

[Read More]

Top Stories for the Week of Dec. 4th, 2006

Tuesday, December 5, 2006

Top News



AstraZeneca to Use Medidata’s eClinical Solutions for All Clinical Trials

The New York, N.Y.-based eClinical company Medidata Solutions has been awarded a major contract from AstraZeneca to provide the company with its Medidata Rave electronic data capture (EDC), replacing AstraZeneca’s present in-house system.

Covance Opens New Phase I Facility in Hawaii

Expanding to meet a growing demand to conduct special trials in specific ethnic patient populations, New Jersey-based contract research organization Covance has opened a new clinical research facility in Honolulu.

Other breaking news…

[Read More]